CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
Tamoxifen is commonly used for breast cancer therapy. However, tamoxifen resistance is an important clinical problem. Continuous treatment with conventional therapy may contribute to cancer progression in recurring cancers through the accumulation ...
